Description

T3 Liothyronine Sodium

Thyroid hormones, specifically T3 Liothyronine Sodium, have garnered interest in research due to their potential interactions with fat mass. A recent study conducted on rats explored the effects of T3 supplementation and found that it did not abolish the increased expression of thyroid hormone receptor beta, which occurs during caloric restriction. Additionally, T3 supplementation led to increased leptin gene expression.

The data suggest that T3 may not significantly elevate metabolic rate but rather mitigate the decline typically observed during prolonged caloric restriction. These findings highlight the potential of T3 as a potential aid in weight loss efforts.

5a-Hydroxy Laxogenin

Laxogenin, also known as 5 alpha hydroxy laxogenin or 5a hydroxy laxogenin, is a compound derived from plants and belongs to a group of compounds called brassinosteroids. While the exact mechanism of its effects is not yet fully understood, as a brassinosteroid, preliminary studies suggest its potential impact on increasing protein synthesis and reducing protein breakdown. Additionally, laxogenin is believed to have the ability to enhance muscle growth and aid in recovery by inhibiting the stress hormone cortisol. Despite ongoing research, further investigation is needed to fully elucidate the mechanisms and potential benefits of laxogenin. It is important to note that this information is strictly related to research purposes.

SR-9011

A recent study conducted on diet-induced obese mice investigated the effects of SR-9009 and SR-9011, administered twice daily for 30 days. The findings revealed a significant reduction in fat mass and notable improvements in dyslipidemia and hyperglycemia. Activation of REV-ERB, induced by these compounds, was observed to enhance the circadian rhythm in mice, impacting various aspects such as behavior, sleep cycles, and functions associated with increased energy production. These results offer valuable insights into the potential of SR9009 and SR-9011 in addressing obesity-related issues and optimizing metabolic function. It is important to note that this study was conducted for research purposes only

GW-0742

GW-0742 is a PPARβ/δ agonist, which is being dubbed as a ‘Super Cardarine’. Studies have shown GW0742 has the ability to improve glucose homeostasis and increase insulin sensitivity in diabetic rats. In diabetic rats fed a high fructose diet, a group given GW0742 showed lower blood sugar compared to the control group. Due to GW0742 being a PPAR agonist, it showed the potential in increasing fat loss by boosting metabolism and stimulating the utilization of fat for fuel. This could potentially increase the oxidative capacity of muscles helping burn more calories.

Yohimbine

Yohimbine is a compound derived from the bark of the Yohimbe tree (Pausinystalia yohimbe) and is of interest in research fields. It is classified as an alpha-2 adrenergic receptor antagonist, which means it blocks the action of these receptors. Yohimbine has been studied for its potential effects on various physiological processes, including its impact on blood flow, and sexual function, and potentially promoting fat loss.

Disclaimer